Literature DB >> 8784091

Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.

E Ghigo1, J Bellone, G Aimaretti, S Bellone, S Loche, M Cappa, E Bartolotta, F Dammacco, F Camanni.   

Abstract

The reliability of provocative stimuli of GH secretion in the diagnosis of GH deficiency is still controversial. Until now, normative values of GH response to various stimuli have not been established properly. In 472 children and adolescents with normal stature (n = 295, height SDS range -1.5 to 1.2) or normal short stature (n = 177, height SDS range -3.7 to -1.8), we studied the GH response to physical exercise, insulin-induced hypoglycemia, arginine (ARG), clonidine, levodopa, glucagon, pyridostigmine (PD), GHRH, PD + GHRH, and ARG + GHRH. The peak GH responses (range) to various stimuli were: 1) physical exercise: 3.0-28.3 micrograms/L; 2) insulin-induced hypoglycemia: 2.7-46.4 micrograms/L; 3) ARG: 0.5-48.4 micrograms/L; 4) clonidine: 3.8-86.0 micrograms/L; 5) levodopa: 1.9-40.0 micrograms/L; 6) glucagon: 1.9-49.5 micrograms/L; 7) PD: 2.5-35.0 micrograms/L; 8) GHRH: 2.7-102.7 micrograms/L; 9)PD + GHRH: 19.6-106.0 micrograms/L; and 10) ARG + GHRH: 19.4-120.0 micrograms/L. Our results show that all conventional stimuli of GH secretion frequently failed to increase GH levels, showing values lower than that arbitrarily assumed, so far, as minimum normal GH peak, i.e. 7 or 10 micrograms/L. When combined with PD or ARG (substances inhibiting hypothalamic somatostatin release), GHRH becomes the most powerful test to explore the secretory capacity of somatotrope cells (the GH response being always higher than 19 micrograms/L). Therefore, only GHRH combined with PD or ARG may be able to clearly differentiate normal children from patients with GH deficiency, though a normal GH response to these tests cannot rule out the existence of GH hyposecretory state because of hypothalamic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784091     DOI: 10.1210/jcem.81.9.8784091

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  57 in total

1.  Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors.

Authors:  A Colao; G Cerbone; R Pivonello; M Klain; G Aimaretti; A Faggiano; C Di Somma; M Salvatore; G Lombardi
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

2.  More guidance on growth hormone deficiency.

Authors:  R Ayling
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

Review 3.  The rational use of pituitary stimulation tests.

Authors:  Stephan Petersenn; Hans-Jürgen Quabbe; Christof Schöfl; Günter K Stalla; Klaus von Werder; Michael Buchfelder
Journal:  Dtsch Arztebl Int       Date:  2010-06-25       Impact factor: 5.594

Review 4.  Diagnosis of adult growth hormone deficiency: still a matter of debate.

Authors:  F Camanni
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

Review 5.  Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED).

Authors:  G Federico; M E Street; M Maghnie; M Caruso-Nicoletti; S Loche; S Bertelloni; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

6.  GH secretion in a cohort of children with pseudohypoparathyroidism type Ia.

Authors:  L de Sanctis; J Bellone; M Salerno; E Faleschini; M Caruso-Nicoletti; M Cicchetti; D Concolino; A Balsamo; F Buzi; L Ghizzoni; C de Sanctis
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

7.  Young elite athletes of different sport disciplines present with an increase in pulsatile secretion of growth hormone compared with non-elite athletes and sedentary subjects.

Authors:  G Ubertini; A Grossi; D Colabianchi; R Fiori; C Brufani; C Bizzarri; G Giannone; A E Rigamonti; A Sartorio; E E Muller; M Cappa
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

8.  Growth hormone response to physical exercise in growing patients with classic congenital adrenal hyperplasia.

Authors:  C Bizzarri; G Ubertini; F Crea; D Colabianchi; S Loche; L Ravà; M Cappa
Journal:  J Endocrinol Invest       Date:  2009-06-24       Impact factor: 4.256

9.  Alström syndrome is associated with short stature and reduced GH reserve.

Authors:  S Romano; P Maffei; V Bettini; G Milan; F Favaretto; M Gardiman; J D Marshall; N A Greggio; G B Pozzan; G B Collin; J K Naggert; R Bronson; R Vettor
Journal:  Clin Endocrinol (Oxf)       Date:  2013-03-26       Impact factor: 3.478

10.  Pituitary function in children following infectious diseases of the central nervous system.

Authors:  Yael Levy-Shraga; Inbal Gazit; Dalit Modan-Moses; Orit Pinhas-Hamiel
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.